Tiny biotech takes on Glaxo’s $730000 gene therapy – San Francisco Chronicle
San Francisco Chronicle |
Tiny biotech takes on Glaxo’s $730000 gene therapy
San Francisco Chronicle Orchard, whose team includes three former Glaxo executives, wants to one-up the larger company by taking aim at a Strimvelis shortcoming. While Glaxo’s therapy can’t be transported, Orchard is planning to use frozen cells that can travel to markets all … |
|
Tiny biotech takes on Glaxo’s $730000 gene therapy
SFGate GlaxoSmithKline has seen precious few takers for its $730,000 gene therapy for a rare and life-threatening immune illness known as “bubble-boy disease.” Now a tiny startup thinks it can succeed where the British giant is struggling. In almost two years … |
|
Tiny biotech takes on Glaxo’s $730000 gene therapy
SFGate GlaxoSmithKline has seen precious few takers for its $730,000 gene therapy for a rare and life-threatening immune illness known as “bubble-boy disease.” Now a tiny startup thinks it can succeed where the British giant is struggling. In almost two years … |
NOLA.com |
This Lusher junior’s stem cell research is sending her to an international science fair
NOLA.com A junior from Lusher Charter School in Uptown was awarded first place in Cell and Molecular Biology at the Greater New Orleans Science and Engineering Fair, where more than 350 middle and high school students from the metropolitan area displayed the … |